Leukemia cutis in a Ph+ ALL patient treated with ponatinib

G Ital Dermatol Venereol. 2018 Oct;153(5):730-731. doi: 10.23736/S0392-0488.17.05647-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Humans
  • Imidazoles / administration & dosage*
  • Leukemic Infiltration / diagnosis*
  • Leukemic Infiltration / drug therapy
  • Leukemic Infiltration / pathology
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Protein Kinase Inhibitors / administration & dosage
  • Pyridazines / administration & dosage*
  • Skin / pathology*

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Protein Kinase Inhibitors
  • Pyridazines
  • ponatinib